Luisa Bonilla

732 total citations
18 papers, 405 citations indexed

About

Luisa Bonilla is a scholar working on Oncology, Reproductive Medicine and Genetics. According to data from OpenAlex, Luisa Bonilla has authored 18 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 6 papers in Reproductive Medicine and 4 papers in Genetics. Recurrent topics in Luisa Bonilla's work include Ovarian cancer diagnosis and treatment (6 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Luisa Bonilla is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Luisa Bonilla collaborates with scholars based in Canada, Israel and Japan. Luisa Bonilla's co-authors include Salomon M. Stemmer, Irit Ben‐Aharon, Anat Gafter‐Gvili, Laura Vidal, L. Leibovici, Lei Dong, Aaron M. Allen, John P. Plastaras, Todd Pawlicki and R Price and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Luisa Bonilla

17 papers receiving 393 citations

Peers

Luisa Bonilla

ONCOL

PRM

RADIA

RNMI

Melissa A. Frick United States

Loredana Costa Italy

Karine A. Al Feghali United States

Michelle Echevarria United States

S. Heymann France

Benedetta Agresti Italy

Hyung‐Sik Lee South Korea

Ezra Hahn Canada

Shira Galper United States

Katherine S. Tzou United States

Melissa A. Frick United States

Luisa Bonilla

160 ×0.7

ONCOL

170 ×1.2

PRM

58 ×0.6

53 ×0.6

RADIA

61 ×1.4

RNMI

Citations per year, relative to Luisa Bonilla Luisa Bonilla (= 1×) peers Melissa A. Frick

Countries citing papers authored by Luisa Bonilla

Since Specialization

Citations

This map shows the geographic impact of Luisa Bonilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Bonilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Bonilla more than expected).

Fields of papers citing papers by Luisa Bonilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Bonilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Bonilla. The network helps show where Luisa Bonilla may publish in the future.

Co-authorship network of co-authors of Luisa Bonilla

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Bonilla. A scholar is included among the top collaborators of Luisa Bonilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Bonilla. Luisa Bonilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Verma, Rohit, et al.. (2024). Anti-MDA5 Antibody-associated Juvenile Dermatomyositis and Rapidly Progressive ILD: A Pediatric Case Report. A2320–A2320.

Madariaga, Ainhoa, Qin Liu, Luisa Bonilla, et al.. (2021). Ethical frameworks in clinical research processes during COVID-19: a scoping review. BMJ Open. 11(7). e047076–e047076. 6 indexed citations

Madariaga, Ainhoa, Gita Bhat, Michelle Wilson, et al.. (2021). Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences. American Journal of Obstetrics and Gynecology. 225(6). 658.e1–658.e9. 5 indexed citations

Madariaga, Ainhoa, Luisa Bonilla, Michelle McMullen, Amit M. Oza, & Stéphanie Lheureux. (2020). Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020. International Journal of Gynecological Cancer. 30(8). 1256–1257. 2 indexed citations

Bonilla, Luisa, et al.. (2020). A brief overview of homologous recombination deficiency testing in cancers for the ‘Next-Generation’ Pathologist. Journal of Pathology of Nepal. 10(2). 1760–1765. 3 indexed citations

Saibil, Samuel D., Luisa Bonilla, Valentin Sotov, et al.. (2019). Fatal Myocarditis and Rhabdomyositis in a Patient with Stage Iv Melanoma Treated with Combined Ipilimumab and Nivolumab. Current Oncology. 26(3). 418–421. 30 indexed citations

Butler, Marcus O., Luisa Bonilla, Norman Franke, et al.. (2019). Effect of minimal lymphodepletion prior to ACT with TBI-1301, NY-ESO-1 specific gene-engineered TCR-T cells, on clinical responses and CRS.. Journal of Clinical Oncology. 37(15_suppl). 2537–2537. 3 indexed citations

Butler, Marcus O., Valentin Sotov, Samuel D. Saibil, et al.. (2019). Adoptive T cell therapy with TBI-1301 results in gene-engineered T cell persistence and anti-tumour responses in patients with NY-ESO-1 expressing solid tumours. Annals of Oncology. 30. v481–v481. 8 indexed citations

Lheureux, Stéphanie, Ana Oaknin, Swati Garg, et al.. (2019). Evolve: A post PARP inhibitor clinical translational phase II trial of cediranib-olaparib in ovarian cancer—A Princess Margaret Consortium – GCIG Phase II Trial.. Journal of Clinical Oncology. 37(15_suppl). 5521–5521. 13 indexed citations

10.

Bonilla, Luisa, Amit M. Oza, Stéphanie Lheureux, et al.. (2019). Clinical outcome of sequential chemotherapy after immune checkpoint inhibitors in advanced ovarian cancer.. Journal of Clinical Oncology. 37(15_suppl). 5580–5580. 2 indexed citations

11.

Bonilla, Luisa, Amit M. Oza, & Stéphanie Lheureux. (2018). Emerging growth factor receptor antagonists for ovarian cancer treatment. Expert Opinion on Emerging Drugs. 23(1). 1–16. 1 indexed citations

12.

Butler, Marcus O., Luisa Bonilla, Valentin Sotov, et al.. (2018). Study of TBI-1301 (NY-ESO-1 specific TCR gene transduced autologous T lymphocytes) in patients with solid tumors. Annals of Oncology. 29. viii441–viii441. 1 indexed citations

13.

Ethier, Josée-Lyne, Luisa Bonilla, Geneviève Bouchard‐Fortier, et al.. (2018). A phase Ib trial of pembrolizumab (Pembro) following adoptive cell therapy (ACT) in patients with platinum-resistant ovarian cancer; The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) trial.. Journal of Clinical Oncology. 36(15_suppl). TPS5611–TPS5611. 1 indexed citations

14.

Colombo, Ilaria, Scott Lien, Cindy Yang, et al.. (2017). Immunologic and genomic characterization of high grade serous ovarian cancer (HGSOC) in patients (pts) treated with pembrolizumab (Pembro) in the phase II INSPIRE trial.. Journal of Clinical Oncology. 35(15_suppl). 5581–5581. 2 indexed citations

15.

Yerushalmi, Rinat, Hadar Goldvaser, Aarón Sulkes, et al.. (2014). Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis. PLoS ONE. 9(10). e107273–e107273. 7 indexed citations

16.

Allen, Aaron M., Todd Pawlicki, Lei Dong, et al.. (2012). An evidence based review of proton beam therapy: The report of ASTRO’s emerging technology committee. Radiotherapy and Oncology. 103(1). 8–11. 160 indexed citations

17.

Hendler, Daniel, Shulamith Rizel, Rinat Yerushalmi, et al.. (2011). Different Schedules of Granulocyte Growth Factor Support for Patients With Breast Cancer Receiving Adjuvant Dose-Dense Chemotherapy. American Journal of Clinical Oncology. 34(6). 619–624. 17 indexed citations

18.

Bonilla, Luisa, Irit Ben‐Aharon, Laura Vidal, et al.. (2010). Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. JNCI Journal of the National Cancer Institute. 102(24). 1845–1854. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact